<i><scp>HCV E1E</scp>2‐<scp>MF</scp>59</i> vaccine in chronic hepatitis <scp>C</scp> patients treated with <scp>PEG</scp>‐<scp>IFN</scp>α2a and <scp>R</scp>ibavirin: a randomized controlled trialP. Colombatto, Ferruccio Bonino, Piero Luigi Almasio et al.|Journal of Viral Hepatitis|2013Cited by 22
602 THE CANDIDATE HCV E1E2MF59 VACCINE IS SAFE IN CHRONIC HEPATITIS C PATIENTS AND ACCELLERATES THE SECOND PHASE VIRAL DECLINE UPON PRIMARY RESPONSE TO PEG-INTERFERON-2A/RIBAVIRIN THERAPYP. Colombatto, Ferruccio Bonino, Maurizia Rossana Brunetto et al.|Journal of Hepatology|2009Cited by 1